Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Hepatoblastoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Granulocyte Colony-Stimulating Factor 5Filgrastim 5Etoposide 4Busulfan 4Thiotepa 3Melphalan 3Ifosfamide 3Carboplatin 3Peripheral Blood Stem Cell Transplantation 2Mesna 2sargramostim 1omburtamab I-131 1etoposide phosphate 1entinostat 1becatecarin 1alvocidib 1Ursodeoxycholic Acid 1Thrombopoietin 1Thalidomide 1Tamoxifen 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Paclitaxel 1Leukapheresis 1LY2940680 1Immunologic Techniques 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Leukapheresis × Other solid neoplasm × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡